Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mallinckrodt

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mallinckrodt's Japan sales performance.

Mallinckrodt

Mallinckrodt doses first patient in muscular dystrophy trial

Mallinckrodt doses first patient in muscular dystrophy trial

Repurposed drug could help delay decline in muscle function. Mallinckrodt has kicked off a phase II trial of its Duchenne muscular dystrophy candidate, a repurposed drug used for years for inflammatory ... Mallinckrodt’s step forward comes shortly

Deal Watch January 2018

Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International. RECOTHROM Thrombin topical and PREVELEAK Surgical Sealant to control bleeding in surgery.

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... Mallinckrodt is paying $18 per share for Sucampo and will also assume the company’s $360m debt under the terms of

Pharma deals continue to slide

Pharma deals continue to slide products. While this may not have been the reason behind GSK’s termination of its rare disease projects, it has not deterred Mallinckrodt from acquiring Infacare, a US company with a ... 469 (upfront 31). Infacare (US). Mallinckrodt (US/GB). Company

Deal Watch August 2016

Deal Watch August 2016 Mallinckrodt (US) Nuclear Imaging business. IBA Molecular (BE). Asset acquisition. Diagnostic imaging products for use in nuclear medicine including molybdenum-99.

1 2 3 4 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...
NHS Long Term Plan - Digital is firmly on the agenda. Are you ready?
The message is clear. To keep pace with the NHS, pharma and healthcare companies must act now and refine their digital strategy to meet the needs of a transforming NHS....

Infographics